Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 12, 2013, Pages 1294-1302

  Zhou, Haihong ^a   Castro Perez, Jose ^a   Lassman, Michael E ^a   Thomas, Tiffany ^b   Li, Wenyu ^a   McLaughlin, Theresa ^a   Dan, Xie ^a   Jumes, Patricia ^a   Wagner, John A ^a   Gutstein, David E ^a   Hubbard, Brian K ^a   Rader, Daniel J ^c   Millar, John S ^c   Ginsberg, Henry N ^b   Reyes Soffer, Gissette ^b   Cleary, Michele ^a   Previs, Stephen F ^a   Roddy, Thomas P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOSYNTHESIS; CARDIOLOGY; DISEASES; ISOTOPES; LIPOPROTEINS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROFLUIDICS; PEPTIDES;

A-STABLE; APOLIPOPROTEINS; CARDIOVASCULAR DISEASE; HUMAN SUBJECTS; MEASUREMENTS OF; MICROFLUIDICS DEVICES; PROTEIN COMPONENTS; RISK FACTORS; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY;

KINETICS;

EID: 84878091121     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6572     Document Type: Article

References (28)

1. B. G. Nordestgaard, M. J. Chapman, K. Ray, J. Boren, F. Andreotti, G. F. Watts, H. Ginsberg, P. Amarenco, A. Catapano, O. S. Descamps, E. Fisher, P. T. Kovanen, J. A. Kuivenhoven, P. Lesnik, L. Masana, Z. Reiner, M. R. Taskinen, L. Tokgozoglu, A. Tybjaerg-Hansen,. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 2010, 31, 2844.
2. A. H. Lichtenstein, J. S. Cohn, D. L. Hachey, J. S. Millar, J. M. Ordovas, E. J. Schaefer,. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. J Lipid Res. 1990, 31, 1693.
3. D. M. Foster, P. H. Barrett, G. Toffolo, W. F. Beltz, C. Cobelli,. Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J. Lipid Res. 1993, 34, 2193.
4. R. Ramakrishnan,. Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments. J. Lipid Res. 2006, 47, 2738.
5. K. G. Parhofer, P. Hugh, R. Barrett, D. M. Bier, G. Schonfeld,. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J. Lipid Res. 1991, 32, 1311.
6. J. C. Price, W. E. Holmes, K. W. Li, N. A. Floreani, R. A. Neese, S. M. Turner, M. K. Hellerstein,. Measurement of human plasma proteome dynamics with (2)H(2)O and liquid chromatography tandem mass spectrometry. Anal. Biochem. 2012, 420, 73.
7. J. S. Andersen, Y. W. Lam, A. K. Leung, S. E. Ong, C. E. Lyon, A. I. Lamond, M. Mann,. Nucleolar proteome dynamics. Nature 2005, 433, 77.
8. Y. Zhang, S. Reckow, C. Webhofer, M. Boehme, P. Gormanns, W. M. Egge-Jacobsen, C. W. Turck,. Proteome scale turnover analysis in live animals using stable isotope metabolic labeling. Anal. Chem. 2011, 83, 1665.
9. H. Zhou, W. Li, S. P. Wang, V. Mendoza, R. Rosa, J. Hubert, K. Herath, T. McLaughlin, R. J. Rohm, M. E. Lassman, K. K. Wong, D. G. Johns, S. F. Previs, B. K. Hubbard, T. P. Roddy,. Quantifying apoprotein synthesis in rodents: coupling LC-MS/MS analyses with the administration of labeled water. J. Lipid Res. 2012, 53, 1223.
10. D. J. Rader, W. Cain, L. A. Zech, D. Usher, H. B. Brewer Jr,. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J. Clin. Invest. 1993, 91, 443.
11. J. L. Jenner, L. J. Seman, J. S. Millar, S. Lamon-Fava, F. K. Welty, G. G. Dolnikowski, S. M. Marcovina, A. H. Lichtenstein, P. H. Barrett, C. deLuca, E. J. Schaefer,. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism 2005, 54, 361.
12. M. E. Frischmann, F. Kronenberg, E. Trenkwalder, J. R. Schaefer, H. Schweer, B. Dieplinger, P. Koenig, K. Ikewaki, H. Dieplinger,. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int. 2007, 71, 1036.
13. T. Demant, K. Seeberg, A. Bedynek, D. Seidel,. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans. Atherosclerosis 2001, 157, 325.
14. J. S. Millar, M. E. Brousseau, M. R. Diffenderfer, P. H. Barrett, F. K. Welty, J. S. Cohn, A. Wilson, M. L. Wolfe, C. Nartsupha, P. M. Schaefer, A. G. Digenio, J. P. Mancuso, G. G. Dolnikowski, E. J. Schaefer, D. J. Rader,. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. J. Lipid Res. 2008, 49, 543.
15. G. M. Fless, C. A. Rolih, A. M. Scanu,. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J. Biol. Chem. 1984, 259, 11470.
16. J. S. Millar, C. Maugeais, K. Ikewaki, D. M. Kolansky, P. H. Barrett, E. C. Budreck, R. C. Boston, N. Tada, S. Mochizuki, J. C. Defesche, J. M. Wilson, D. J. Rader,. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 560.
17. S. M. Marcovina, J. J. Albers, B. Gabel, M. L. Koschinsky, V. P. Gaur,. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 1995, 41, 246.
18. Wolfe RR, Chinkes DL,. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analyses. Wiley-Liss, Hoboken, NJ, 2005.
19. E. Belloto, F. Diraison, A. Basset, G. Allain, P. Abdallah, M. Beylot,. Determination of protein replacement rates by deuterated water: validation of underlying assumptions. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1340.
20. F. Jahoor, D. G. Burrin, P. J. Reeds, M. Frazer,. Measurement of plasma protein synthesis rate in infant pig: an investigation of alternative tracer approaches. Am. J. Physiol. 1994, 267, R221-R227.
21. H. Brunengraber, J. K. Kelleher, C. DesRosiers,. Applications of mass isotopomer analysis to nutrition research. Annu. Rev. Nutr. 1997, 17, 559.
22. C. Papageorgopoulos, K. Caldwell, C. Shackleton, H. Schweingrubber, M. K. Hellerstein,. Measuring protein synthesis by mass isotopomer distribution analysis (MIDA). Anal. Biochem. 1999, 267, 1.
23. D. M. Tomazela, B. W. Patterson, E. Hanson, K. L. Spence, T. B. Kanion, D. H. Salinger, P. Vicini, H. Barret, H. B. Heins, F. S. Cole, A. Hamvas, M. J. MacCoss,. Measurement of human surfactant protein-B turnover in vivo from tracheal aspirates using targeted proteomics. Anal. Chem. 2010, 82, 2561.
24. Waters Corporation. Chromatographic reproducibility of TRIZAIC nanoTile technology. [serial online], 2012. Available: http://www.waters.com/waters/ library.htm?cid=511436&lid=134652984 (accessed January 7, 2013).
25. M. S. Bereman, D. M. Tomazela, H. S. Heins, M. Simonato, P. E. Cogo, A. Hamvas, B. W. Patterson, F. S. Cole, M. J. MacCoss,. A method to determine the kinetics of multiple proteins in human infants with respiratory distress syndrome. Anal. Bioanal. Chem. 2012, 403, 2397.
26. M. J. MacCoss, C. C. Wu, D. E. Matthews, J. R. Yates III,. Measurement of the isotope enrichment of stable isotope-labeled proteins using high-resolution mass spectra of peptides. Anal. Chem. 2005, 77, 7646.
27. 2O labeling to quantify static and dynamic changes in cholesterol and cholesterol esters by high resolution LC/MS. J. Lipid Res. 2011, 52, 159.
28. J. M. Castro-Perez, T. P. Roddy, V. Shah, D. G. McLaren, S. P. Wang, K. Jensen, R. J. Vreeken, T. Hankemeier, D. G. Johns, S. F. Previs, B. K. Hubbard,. Identifying static and kinetic lipid phenotypes by high resolution UPLC-MS: unraveling diet-induced changes in lipid homeostasis by coupling metabolomics and fluxomics. J. Proteome. Res. 2011, 10, 4281.